Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease.
Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
Substance Name: Amiloride
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Control of experimental autoimmune uveoretinitis by low dose T cell vaccination.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
Neuropathology of white matter disease in Leber's hereditary optic neuropathy.
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis.
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.

Pages